Qualigen Therapeutics Received Nasdaq Notice Of A Delisting Determination

QIAGEN NV -0.21%

QIAGEN NV

QGEN

42.48

-0.21%

Qualigen Therapeutics, Inc. (("Qualigen" or "the Company, NASDAQ:QLGN), announced today that on May 23, 2024, it received written notice (the "Delist Notice") from The Nasdaq Stock Market ("Nasdaq") indicating the Company's continued non-compliance with the minimum bid price requirement, pursuant to Listing Rule 5550(b)(2). 

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via